Thomayant Prueksaritanont Selected Research

Proteins (Proteins, Gene)

2/2021	Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.
1/2021	Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach.
1/2020	SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population.
9/2014	Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
3/2013	In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters.
7/2008	Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refractory cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomayant Prueksaritanont Research Topics

Disease

12	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2016 - 07/2009
6	Inflammation (Inflammations) 07/2008 - 12/2004
5	Breast Neoplasms (Breast Cancer) 02/2021 - 03/2013
3	Pain (Aches) 07/2008 - 01/2007
3	Chronic Pain 01/2008 - 12/2004
3	Osteoporosis 09/2004 - 12/2003
2	Chronic Renal Insufficiency 01/2021 - 01/2020
2	Neoplasms (Cancer) 04/2010 - 07/2008
1	Hypercholesterolemia 02/2021
1	Muscular Diseases (Myopathy) 01/2020
1	Anemia 12/2012
1	Epilepsy (Aura) 05/2010
1	Tremor (Tremors) 05/2010
1	Hyperglycemia 04/2010
1	Sleep Wake Disorders 04/2010
1	Seizures (Absence Seizure) 10/2008
1	Parkinson Disease (Parkinson's Disease) 10/2008
1	Absence Epilepsy (Childhood Absence Epilepsy) 10/2008
1	Essential Tremor (Essential Tremors) 10/2008
1	Carcinoma (Carcinomatosis) 04/2006
1	Dehydration (Water Stress) 01/2006
1	Dyslipidemias (Dyslipidemia) 09/2004
1	Bone Resorption 12/2003

Drug/Important Bio-Agent (IBA)

8	Orexin Receptor AntagonistsIBA 10/2016 - 07/2010
7	OrexinsIBA 11/2015 - 07/2009
6	Proteins (Proteins, Gene)FDA Link 02/2021 - 07/2008
5	Peptides (Polypeptides)IBA 02/2021 - 03/2013
4	AnionsIBA 02/2021 - 03/2013
3	BradykininIBA 07/2008 - 06/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021 - 01/2020
2	pitavastatin (itavastatin)FDA Link 02/2021 - 01/2021
2	Rosuvastatin Calcium (Crestor)FDA Link 02/2021 - 01/2021
2	Organic Anion TransportersIBA 01/2020 - 09/2014
2	AmidesIBA 11/2015 - 04/2006
2	Orexin ReceptorsIBA 11/2015 - 04/2010
2	ATP-Binding Cassette Sub-Family B Member 4IBA 09/2014 - 03/2013
2	compound 30IBA 10/2008 - 07/2008
2	Bradykinin B1 Receptor AntagonistsIBA 01/2007 - 12/2004
2	Simvastatin (Zocor)FDA LinkGeneric 01/2006 - 09/2004
1	Pravastatin (Pravachol)FDA LinkGeneric 02/2021
1	Atorvastatin (Lipitor)FDA Link 02/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Allopurinol (Remid)FDA LinkGeneric 01/2020
1	suvorexantIBA 11/2015
1	Rifampin (Rifampicin)FDA LinkGeneric 09/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2013
1	Erythropoietin FDA Link 12/2012
1	NeuropeptidesIBA 03/2012
1	GABA ModulatorsIBA 03/2012
1	QuinazolinonesIBA 05/2010
1	Growth Factor ReceptorsIBA 04/2010
1	Glucose (Dextrose)FDA LinkGeneric 04/2010
1	Insulin (Novolin)FDA Link 04/2010
1	KinesinsIBA 07/2008
1	taxaneIBA 07/2008
1	PyrrolesIBA 07/2008
1	Cytotoxins (Cytolysins)IBA 07/2008
1	pyrrolineIBA 04/2006
1	Urea (Carbamide)FDA LinkGeneric 04/2006
1	Bradykinin B1 ReceptorIBA 02/2006
1	LactonesIBA 01/2006
1	Fenofibrate (CiL)FDA LinkGeneric 09/2004
1	Lipid Regulating AgentsIBA 09/2004
1	Integrin alphaVbeta3IBA 08/2004
1	propionic acid (potassium propionate)IBA 08/2004
1	S 6 (S-6)IBA 08/2004
1	IntegrinsIBA 12/2003

Therapy/Procedure

3	Therapeutics 02/2015 - 04/2010
1	Oral Administration 09/2004